$ 67.49
Updated 10:05:04
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 100
High $ 69.87
Low $ 65.92
Open $ 69.22
ISIN
Prev close $ 68.15
# of shares 1,293.62M
Market cap 87,306M USD
Intraday

Market closed
Gilead Sciences Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  67.49 -3.0% Stock price decreasing -5.2% Stock price decreasing -6.6% Stock price decreasing -6.0% Stock price decreasing -11.1% Stock price decreasing
Powered by TradingView

News about Gilead Sciences Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 70.92 -0.8% Stock price decreasing -2.6% Stock price decreasing 6.5% Stock price increasing 12.3% Stock price increasing 29.1% Stock price increasing 24.3% Stock price increasing
 
Bristol-Myers Squibb Company 52.58 1.1% Stock price increasing -1.5% Stock price decreasing -13.1% Stock price decreasing -1.0% Stock price decreasing -16.6% Stock price decreasing -14.2% Stock price decreasing
 
Merck & Company Inc (new) 77.42 -1.0% Stock price decreasing 3.4% Stock price increasing 12.1% Stock price increasing 24.2% Stock price increasing 37.4% Stock price increasing 37.6% Stock price increasing
 
Pfizer Inc 44.40 -1.6% Stock price decreasing 0.3% Stock price increasing 4.9% Stock price increasing 22.3% Stock price increasing 22.6% Stock price increasing 22.6% Stock price increasing
 
Amgen Inc 194.09 -1.9% Stock price decreasing 0.5% Stock price increasing -2.7% Stock price decreasing 5.1% Stock price increasing 9.8% Stock price increasing 11.6% Stock price increasing
 
Celgene Corporation 68.68 -5.2% Stock price decreasing -7.2% Stock price decreasing -21.3% Stock price decreasing -12.3% Stock price decreasing -36.4% Stock price decreasing -34.2% Stock price decreasing
 
Novartis NAM SF 0,50 76.58 -5.6% Stock price decreasing -2.5% Stock price decreasing 5.9% Stock price increasing 19.2% Stock price increasing 7.8% Stock price increasing 8.4% Stock price increasing
 
Roche Hldg AG GEN 222.80 -2.9% Stock price decreasing 2.6% Stock price increasing 6.8% Stock price increasing 24.1% Stock price increasing 8.9% Stock price increasing 5.8% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,493.40 -1.2% Stock price decreasing -4.9% Stock price decreasing -0.1% Stock price decreasing -2.8% Stock price decreasing 14.6% Stock price increasing 12.9% Stock price increasing
 
Sanofi 78.78 -0.4% Stock price decreasing -1.8% Stock price decreasing 7.5% Stock price increasing 17.8% Stock price increasing 7.1% Stock price increasing 9.6% Stock price increasing
 
Biogen Inc 319.44 -1.0% Stock price decreasing -1.8% Stock price decreasing -5.4% Stock price decreasing 4.2% Stock price increasing -2.6% Stock price decreasing 0.3% Stock price increasing

Company profile

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.

Peers

Instruments Last Change  
Abbott Labor.. 70.92 1.4% Stock price increasing
Bristol-Myer.. 52.58 -0.9% Stock price decreasing
Merck & Comp.. 77.42 0.9% Stock price increasing
Pfizer Inc 44.40 1.1% Stock price increasing
Amgen Inc 194.09 0.0% Stock price unchanged
Celgene Corp.. 68.68 0.0% Stock price unchanged
Novartis NAM.. 76.58 1.3% Stock price increasing
Roche Hldg A.. 222.80 2.2% Stock price increasing
Glaxosmithkl.. 1,493.40 1.6% Stock price increasing
Sanofi 78.78 2.4% Stock price increasing
Biogen Inc 319.44 0.0% Stock price unchanged

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 10:20:23
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB5 - 2018-12-11 11:20:23 - 2018-12-11 10:20:23 - 1000 - Website: OKAY